Detalles de la búsqueda
1.
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Cancer Immunol Immunother
; 72(11): 3707-3716, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37638980
2.
Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictors.
BMJ Support Palliat Care
; 2023 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37666650
3.
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity.
Explor Target Antitumor Ther
; 4(4): 743-756, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37720351
4.
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors.
Tumori
; 108(1): 47-55, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002648
5.
Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals.
Acta Biomed
; 92(3): e2021091, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34212933
6.
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.
Immunotherapy
; 12(15): 1139-1148, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32933369
7.
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Lung Cancer
; 150: 123-131, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33130353
8.
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC.
Lung Cancer
; 131: 78-85, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31027702
9.
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma.
Immunotherapy
; 11(1): 21-35, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30702014
10.
Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab.
Immunotherapy
; 10(9): 743-752, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30008256
11.
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab.
Immunotherapy
; 10(8): 681-694, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29882691
12.
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.
Immunotherapy
; 10(14): 1229-1239, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30326787
Resultados
1 -
12
de 12
1
Próxima >
>>